Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-29 Purchase | 2024-11-05 12:42 pm | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 13,252,112 | $0 | $0 | 29,823,881 (Direct) | View |
| 2022-12-02 Purchase | 2022-12-06 9:02 pm | Eterna Therapeutics Inc. | ERNA | Cherington Charles Director 10% Owner | 261,756 | $3.28 | $858,560 | 1,079,977 (Direct) | View |
| 2022-12-02 Purchase | 2022-12-06 6:52 pm | Eterna Therapeutics Inc. | ERNA | Singer Nicholas Jason Director | 283,286 | $3.28 | $929,178 | 832,786 (Indirect) | View |
| 2022-12-02 Purchase | 2022-12-05 6:05 pm | Eterna Therapeutics Inc. | ERNA | HALPERN JOHN D 10% Owner | 335,920 | $3.28 | $1,101,818 | 1,123,006 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Wexler William A. Director | 124,533 | $0 | 124,533 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 150,000 | $0 | 150,000 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Bristol James Arthur Director | 72,074 | $0 | 72,074 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Cicala Peter Director | 51,485 | $0 | 51,485 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Luther Sanjeev President & CEO | 1,123,350 | $0 | 1,123,350 (Direct) | View |
| 2025-01-13 Option Award | 2025-01-14 5:01 pm | N/A 2035-01-13 | Eterna Therapeutics Inc. | ERNA | Ratner Elena Director | 140,078 | $0 | 140,078 (Direct) | View |
| 2024-10-29 Conversion | 2024-11-05 12:42 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 2,819,546 | $0.5 | 29,823,881 (Direct) | View |
| 2024-10-29 Conversion | 2024-11-05 12:42 pm | N/A 2025-09-24 | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 1,368,626 | $0 | 29,823,881 (Direct) | View |
| 2024-06-21 Tax Withholding | 2024-06-25 4:32 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 180 | $1.94 | 1,622 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 4:32 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 437 | $0 | 1,622 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-29 4:31 pm | N/A 2034-04-26 | Eterna Therapeutics Inc. | ERNA | Cicala Peter Director | 88,946 | $0 | 88,946 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-29 4:30 pm | N/A 2034-04-26 | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 80,000 | $0 | 80,000 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-29 4:30 pm | N/A 2034-04-26 | Eterna Therapeutics Inc. | ERNA | Bristol James Arthur Director | 124,525 | $0 | 124,525 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:02 pm | N/A 2034-01-01 | Eterna Therapeutics Inc. | ERNA | Luther Sanjeev President and CEO | 1,685,218 | $0 | 1,685,218 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:01 pm | N/A 2034-01-01 | Eterna Therapeutics Inc. | ERNA | Clarke Dorothy J General Counsel Director | 168,521 | $0 | 168,521 (Direct) | View |
| 2023-12-14 Expired | 2023-12-20 10:05 am | 2023-07-14 2028-07-14 | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 2,831,204 | $0 | 8,957,180 (Direct) | View |
| 2023-12-14 Disposition | 2023-12-18 9:38 pm | 2023-06-02 2028-06-02 | Eterna Therapeutics Inc. | ERNA | Freebird Partners LP Freebird Investments LLC HUFF CURTIS W 10% Owner | 949,402 | $0 | 5,622,833 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 9:38 pm | 2023-06-02 2028-06-02 | Eterna Therapeutics Inc. | ERNA | Freebird Partners LP Freebird Investments LLC HUFF CURTIS W 10% Owner | 949,402 | $0 | 5,622,833 (Direct) | View |
| 2023-06-21 Tax Withholding | 2023-06-23 8:30 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Vice President of Finance | 179 | $2.48 | 1,802 (Direct) | View |
| 2023-06-21 Exercise | 2023-06-23 8:30 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Vice President of Finance | 438 | $0 | 1,802 (Direct) | View |
Ownership | 2023-04-04 5:03 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Freebird Partners LP Freebird Investments LLC HUFF CURTIS W 10% Owner | 0 | $0 | 697,510 (Direct) | View |
Ownership | 2023-03-06 4:01 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | DENNY GEORGE P III 10% Owner | 0 | $0 | 460,413 (Indirect) | View |
| 2023-01-12 Option Award | 2023-01-13 7:30 pm | N/A 2033-01-12 | Eterna Therapeutics Inc. | ERNA | Angel Matthew President and CEO | 132,003 | $0 | 132,003 (Direct) | View |
| 2022-09-20 Exercise | 2022-09-21 7:00 pm | N/A N/A | Brooklyn ImmunoTherapeutics Inc. | BTX | Sidhu Roger Chief Medical Officer | 20,163 | $0 | 80,650 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 8:01 pm | N/A 2032-08-01 | Brooklyn ImmunoTherapeutics Inc. | BTX | Angel Matthew Interim President and CEO | 2,487,003 | $0 | 2,487,003 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 8:01 pm | N/A 2032-08-01 | Brooklyn ImmunoTherapeutics Inc. | BTX | Cherington Charles Director | 380,900 | $0 | 380,900 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 8:01 pm | N/A 2032-08-01 | Brooklyn ImmunoTherapeutics Inc. | BTX | Fiore Gregory Director | 260,900 | $0 | 260,900 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-03 8:01 pm | N/A 2032-08-01 | Brooklyn ImmunoTherapeutics Inc. | BTX | Wexler William A. Director | 317,900 | $0 | 317,900 (Direct) | View |